Morphine Antinociception Medullary Pain Modulating Neurons and Reduce Kappa Opioids Inhibit Physiologically Identified (original) (raw)

Profile image of Nigel PedersenNigel Pedersen

2012

visibility

description

8 pages

link

1 file

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact

Opioids in neuropathic pain: clues from animal studies

Rie Suzuki

European Journal of Pain, 2005

View PDFchevron_right

Morphine-Induced -Opioid Receptor Desensitization

Vu Dang

Molecular Pharmacology, 2005

View PDFchevron_right

Route of morphine administration modulates conditioned analgesic tolerance and hyperalgesia

Judith Grisel

Pharmacology Biochemistry and Behavior, 1994

View PDFchevron_right

Principles of opioid use in chronic noncancer pain

Jackie McMillan

PubMed, 2003

View PDFchevron_right

Opiate and stimulus-produced analgesia: functional anatomy of a medullospinal pathway

Charles Clanton

Proceedings of the …, 1976

View PDFchevron_right

Characterization of Opioid Receptors in Cultured Neurons

John Kessler

Journal of Neurochemistry, 1990

View PDFchevron_right

Serotonin receptor antagonists induce hyperalgesia without preventing morphine antinociception

Odd-Geir Berge

Pharmacology, Biochemistry and Behavior, 1983

View PDFchevron_right

Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance

enrique contreras

European Journal of Pharmacology, 1988

View PDFchevron_right

Opioids in chronic non-cancer pain

Laxmaiah Manchikanti

Expert Opinion on Pharmacotherapy, 2011

View PDFchevron_right

Pain-Induced Negative Affect Is Mediated via Recruitment of The Nucleus Accumbens Kappa Opioid System

Lucía Hipólito

Neuron, 2019

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

Opioids in chronic non-cancer pain, indications and controversies

Harald Breivik

European Journal of Pain, 2005

View PDFchevron_right

Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval

Wojciech Danysz

European Journal of Pharmacology, 2000

View PDFchevron_right

Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers

Anne Bossard

Pain, 2002

View PDFchevron_right

Neuropathic Pain Activates the Endogenous Opioid System in Mouse Spinal Cord and Induces Opioid Receptor Tolerance

John Pintar

Journal of Neuroscience, 2004

View PDFchevron_right

Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteers

A. Sollevi

Acta Anaesthesiologica Scandinavica, 2003

View PDFchevron_right

The Mechanisms Involved in Morphine Addiction: An Overview

Małgorzata Łupina

International Journal of Molecular Sciences, 2019

View PDFchevron_right

Opioid Therapy for Chronic Pain

Jane Ballantyne

New England Journal of Medicine, 2003

View PDFchevron_right

Chronic opioid antagonist treatment increases μ and δ receptor mediated spinal cord opioid analgesia

Dennis Paul

Brain Research, 1989

View PDFchevron_right

Opioid Guidelines in the Management of Chronic Non-Cancer Pain

Laxmaiah Manchikanti

Pain Physician, 2006

View PDFchevron_right

Etorphine increases the number of μ-opioid receptor-positive cells in the cerebral cortex

Fiorenzo Conti

Neuroscience, 2000

View PDFchevron_right

Disruption of the kappa -opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa -agonist U-50,488H and attenuates morphine withdrawal

Olga Valverde

1998

View PDFchevron_right

Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways

A. Nejdi

Proceedings of the National Academy of Sciences, 2006

View PDFchevron_right

Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray

Sheralee Tershner

Brain Research, 2000

View PDFchevron_right

A Clinical Approach to Neuraxial Morphine for the Treatment of Postoperative Pain

Borja Mugabure

View PDFchevron_right

Development of tolerance to antinociceptive effects of an intrathecal morphine/clonidine combination in rats

P. Cmielewski

Naunyn-Schmiedeberg's Archives of Pharmacology, 1995

View PDFchevron_right

μ-Opioid Receptors: Ligand-Dependent Activation of Potassium Conductance, Desensitization, and Internalization

Vu Dang

The Journal of Neuroscience, 2002

View PDFchevron_right

Opioid and the usage in chronic non cancer pain

Boyke Marthin Simbolon

Jurnal Prima Medika Sains, 2023

View PDFchevron_right

Affective analgesia following the administration of morphine into the amygdala of rats

padmaja Nandigama

Brain Research, 2003

View PDFchevron_right

Analgesia induced by localized injection of opiate peptides into the brain of infant rats

Gordon Barr

European Journal of Pain, 2012

View PDFchevron_right

Endogenous morphine

MASSIMO GUARNA

Trends in Neurosciences, 2000

View PDFchevron_right

Central mechanisms of pain modulation

Gulnazi Gurtskaia

Current Opinion in Neurobiology, 1999

View PDFchevron_right

Methadone Antinociception Is Dependent on Peripheral Opioid Receptors

joseph kim

The Journal of Pain, 2009

View PDFchevron_right

Peripherally Acting μ-Opioid Receptor Agonists Attenuate Ongoing Pain-associated Behavior and Spontaneous Neuronal Activity after Nerve Injury in Rats

Srinivasa Raja

Anesthesiology, 2018

View PDFchevron_right

A fall from grace: exposing the neurotoxicities of morphine

Sam Ahmedzai

British Journal of Pain, 2016

View PDFchevron_right

Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain

Jürgen Lorenz

Pain, 1997

View PDFchevron_right

MedicineMorphineOpioid